Gardenoside is a bioactive small molecule with demonstrated hepatoprotective, analgesic, and anti-inflammatory properties. Research indicates its potential in NASH studies, where it suppresses pro-inflammatory cytokines and NF-kappaB activity in vitro, and it may act as a purinergic receptor modulator targeting P2X3 and P2X7 pathways.